ARUP analyzes by mass spectrometry up front, eliminating the need for reflex testing in most cases.
Mass spectrometry is the gold standard for drug detection and is usually used only to confirm positive results from a preliminary screen. By eliminating the screen, the potential for inaccurate results is reduced and time-consuming reflex testing is avoided.

Quick turnaround times and 24/7 service provide timely care and can reduce overall costs.
Testing is performed 7 days/week. Additionally, client services and on-call pathologists are available 24/7. Therefore, results can be received faster, which has the potential to provide more timely care and reduce costs.

Interfaced results, enhanced reports, and drug-positivity dashboards help caregivers provide excellent care.
Results can be received through an interface for seamless integration of all patient results. Enhanced reports help caregivers clearly read patient test results. ARUP’s dashboard benchmarks test positivity rates against state and national averages and can be used in various public health initiatives.